IntelliCentrics Appoints Charles Christopherson Chief Financial Officer
DALLAS, January 9, 2020 (Newswire.com) - IntelliCentrics Inc., owner and operator of the SEC3URE Ethos, which is the world’s largest healthcare technology platform dedicated to ensuring trust between all stakeholders across the continuum of care, announced today that Charles Christopherson has been appointed Chief Financial Officer. Mr. Christopherson will be responsible for developing the company’s global financial strategies, ensuring exceptional value to all company shareholders, and will report to Michael Sheehan, the company’s Chief Executive Officer.
Christopherson joined IntelliCentrics from BT America, where he served as the global CFO leading the British telecom giant’s operations in the Americas and global teams in the consumer products, pharmaceutical and chemical verticals. Prior to that, he was the senior vice president of the Global Industry Business Unit (IBU) for Project System Administrative Solutions at SAP. During his tenure, Christopherson oversaw the global business strategy and software development of the IBU’s financial, human capital and business intelligence solutions.
“We are very excited about the unique leadership and talent that Charles brings to our team,” said CEO Sheehan. “He’s an experienced financial executive with a proven record in driving value for customers through innovation and value for shareholders alike. We are confident that his extensive experience in finance, IT and business operations will help us achieve our full potential.”
Christopherson has held various leadership positions at technology companies – private and public – throughout a career that spans nearly three decades. He earned his bachelor’s degree in accounting from Brigham Young University and his MBA from the University of Oregon.
“I am thrilled to join IntelliCentrics and become part of a dynamic, forward-looking team,” said Christopherson. “IntelliCentrics has created the world’s largest trusted healthcare community between all stakeholders in the entire continuum of care. There is a huge opportunity to take the company and our innovations to great heights. I can’t wait to see what we can accomplish.”